Literature DB >> 15199080

Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: effect in occasional and chronic users.

Laura L Boles Ponto1, Daniel S O'Leary, Julie Koeppel, Robert I Block, G Leonard Watkins, John C W Richmond, Christine A Ward, Dean A Clermont, Beth A Schmitt, Richard D Hichwa.   

Abstract

The objective of this study was to evaluate the effect of the acute administration of marijuana (MJ) on cardiovascular (CV) function and CNS pharmacokinetics (PK) of [(15)O]water in occasional (O) versus chronic (C) MJ users. Each subject received four injections of [(15)O]water (one prior and three postsmoking) on two occasions in which they received active or placebo MJ. For each injection, measures of CV function and CNS PK [(15)O]water were made. Postsmoking, MJ influenced all measured CV and [(15)O]water PK parameters. C users reported significantly lower "highness" and smaller heart rate (HR) changes, which resulted in reduced rate pressure product (RPP) changes compared to O users, even though Delta(9)-tetrahydrocannabinol levels were higher, whereas changes in blood pressure (BP), arrival time, and [(15)O]water concentration were not significantly different between the groups. Significant CV changes resulted in changes in the whole-body distribution of cardiac output rather than changes in cerebral blood flow. Chronic MJ use produces tolerance to the HR increases induced by acute MJ smoking compared to changes observed in occasional users, without changing the effects on BP and [(15)O]water PK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199080     DOI: 10.1177/0091270004265699

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  14 in total

1.  Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers.

Authors:  Nathalie A Desrosiers; Johannes G Ramaekers; Emeline Chauchard; David A Gorelick; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-03-04       Impact factor: 3.367

2.  Lifetime substance misuse and 5-year incidence rates of emergent health problems among middle-aged adults.

Authors:  Kristin M Caspers; Rebecca Yucuis; Lowell M McKirgan; Ruth Spinks; Stephan Arndt
Journal:  J Addict Dis       Date:  2009-10

3.  Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence.

Authors:  Wilfrid Noel Raby; Kenneth M Carpenter; Jami Rothenberg; Adam C Brooks; Huiping Jiang; Maria Sullivan; Adam Bisaga; Sandra Comer; Edward V Nunes
Journal:  Am J Addict       Date:  2009 Jul-Aug

4.  Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

Authors:  David A Gorelick; Robert S Goodwin; Eugene Schwilke; David M Schwope; William D Darwin; Deanna L Kelly; Robert P McMahon; Fang Liu; Catherine Ortemann-Renon; Denis Bonnet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-10-16       Impact factor: 3.367

5.  Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders.

Authors:  Kevin M Gray; Carl L Hart; Douglas K Christie; Himanshu P Upadhyaya
Journal:  Pharmacol Biochem Behav       Date:  2008-06-26       Impact factor: 3.533

6.  Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses.

Authors:  S Jayanthi; S Buie; S Moore; R I Herning; W Better; N M Wilson; C Contoreggi; J L Cadet
Journal:  Mol Psychiatry       Date:  2008-05-13       Impact factor: 15.992

7.  Regular cannabis use is associated with blunted affective, but not cardiovascular, stress responses.

Authors:  Briana N DeAngelis; Mustafa al'Absi
Journal:  Addict Behav       Date:  2020-03-23       Impact factor: 4.591

8.  Oroxylin a, but not vasopressin, ameliorates cardiac dysfunction of endotoxemic rats.

Authors:  Chin-Hung Liu; Mei-Fang Chen; Tzu-Ling Tseng; Lih-Geeng Chen; Jon-Son Kuo; Tony Jer-Fu Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-24       Impact factor: 2.629

9.  The coronary dilation effect of shen fu injection was mediated through NO.

Authors:  Yu Hong Li; Bin Yu; Zhen Zhen Duan; Olunga Mary Akinyi; Jia Hui Yu; Kun Zhou; Yue Zhang; Xiu Mei Gao
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study.

Authors:  Albert Stuart Reece; Amanda Norman; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2016-11-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.